(Q61921342)
Statements
An Open-label Multicenter Phase II Study of Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors (English)
0 references
May 2006
0 references
April 2009
0 references
11
0 references
18 year
0 references